Immorta Bio, a Scientific Longevity Company, Selected for NYU Stern's Prestigious Endless Frontier Labs 2026-27 Life Sciences Cohort

Positive

AI Analysis

Summary

Immorta Bio, a scientific longevity company, has been selected for NYU Stern's Endless Frontier Labs 2026-27 Life Sciences Cohort, providing access to an ecosystem designed to accelerate breakthrough science toward clinical and commercial success.

Importance:3/10

Sentiment:

0.60

longevityacceleration programNYU partnershiplife sciences

Related Companies

$XAGEW

Read the original article

Published by PR Newswire Biotech on September 23, 2026 12:41 PM

Read Original